natgillin/translations-raw huggingface dataset:
odobri nespremenjeno stališče Sveta o predlogu spremembe proračuna št. 7/2010 in naroči svojemu predsedniku, naj razglasi, da je sprememba proračuna št. 5/2010 dokončno sprejeta, ter poskrbi za njeno objavo v
Approves Council's position on Draft amending budget No 7/2010 unamended and instructs its President to declare that Amending budget No 5/2010 has been definitively adopted and to arrange for its publication in the
Zakonodajna resolucija Evropskega parlamenta z dne 22. septembra 2010 o predlogu direktive Sveta o spremembi Direktive 2008/9/ES o podrobnih pravilih za vračilo davka na dodano vrednost, opredeljenih v Direktivi 2006/112/ES, davčnim zavezancem, ki nimajo sedeža v državi članici vračila, ampak v drugi državi članici ( KOM(2010)0381 – C7-0201/2010 – 2010/0205(CNS) )
European Parliament legislative resolution of 22 September 2010 on the proposal for a Council directive amending Directive 2008/9/EC laying down detailed rules for the refund of value added tax, provided for in Directive 2006/112/EC, to taxable persons not established in the Member State of refund but established in another Member State ( COM(2010)0381 – C7-0201/2010 – 2010/0205(CNS) )
ob upoštevanju predloga Komisije Svetu ( KOM(2010)0381 ),
having regard to the Commission proposal to the Council ( COM(2010)0381 ),
ob upoštevanju člena 113 Pogodbe o delovanju Evropske unije, v skladu s katerim se je Svet posvetoval s Parlamentom ( C7-0201/2010 ),
having regard to Article 113 of the Treaty on the Functioning of the European Union pursuant to which the Council consulted Parliament ( C7-0201/2010 ),
ob upoštevanju mnenja Evropskega ekonomsko-socialnega odbora z dne 15. septembra 2010 Še ni objavljeno v uradnem listu.
having regard to the opinion of the European Economic and Social Committee of 15 September 2010 Not yet published in the Official Journal.
ob upoštevanju mnenja Odbora za ekonomske in monetarne zadeve ( A7-0247/2010 ),
having regard to the report of the Committee on Economic and Monetary Affairs ( A7-0247/2010 ),
poziva Komisijo, naj ustrezno spremeni svoj predlog na podlagi člena 293(2) Pogodbe o delovanju Evropske unije;
Calls on the Commission to alter its proposal accordingly, pursuant to Article 293(2) of the Treaty on the Functioning of the European Union;
za izvajanje podrobnih pravil za elektronsko predložitev in obvestila v skladu z Direktivo 2008/9/ES, po potrebi vključno s skupnimi obrazci
for the implementation of the detailed rules, including common forms where necessary, on the electronic submissions and notifications referred to in Directive 2008/9/EC
, je treba sprejeti v skladu s Sklepom Sveta 1999/468/ES z dne 28. junija 1999 o določitvi postopkov za uresničevanje Komisiji podeljenih izvedbenih pooblastil
should be adopted in accordance with Council Decision 1999/468/EC of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission
Treba bi bilo zagotoviti enotne pogoje
Uniform conditions should be ensured
za izvajanje podrobnih pravil za elektronsko predložitev in obvestila v skladu z Direktivo 2008/9/ES, po potrebi vključno s skupnimi obrazci.
for the implementation of the detailed rules, including common forms where necessary, on the electronic submissions and notifications referred to in Directive 2008/9/EC.
Do sprejetja take uredbe se še naprej uporablja Sklep Sveta 1999/468/ES z dne 28. junija 1999 o določitvi postopkov za uresničevanje Komisiji podeljenih izvedbenih pooblastil
Pending the adoption of such a regulation, Council Decision 1999/468/EC of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission
, razen regulativnega postopka s pregledom, ki se ne uporablja v okviru te direktive.
continues to apply, with the exception of the regulatory procedure with scrutiny, which is not applicable within the framework of this Directive.
Zakonodajna resolucija Evropskega parlamenta z dne 22. septembra 2010 o predlogu uredbe Evropskega parlamenta in Sveta o spremembi Uredbe (ES) št. 726/2004 o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila, kar zadeva farmakovigilanco zdravil za humano uporabo ( KOM(2008)0664 – C6-0515/2008 – 2008/0257(COD) )
European Parliament legislative resolution of 22 September 2010 on the proposal for a regulation of the European Parliament and of the Council amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency ( COM(2008)0664 – C6-0515/2008 – 2008/0257(COD) )
ob upoštevanju predloga Komisije Evropskemu parlamentu in Svetu ( KOM(2008)0664 ),
having regard to the Commission proposal to the European Parliament and the Council ( COM(2008)0664 ),
ob upoštevanju člena 251(2) in člena 95 Pogodbe ES, na podlagi katerih je Komisija Parlamentu podala predlog ( C6-0515/2008 ),
having regard to Article 251(2) and Article 95 of the EC Treaty, pursuant to which the Commission submitted the proposal to Parliament ( C6-0515/2008 ),
ob upoštevanju členov 294(3), 114 in 168(4)(c) Pogodbe o delovanju Evropske unije,
having regard to Article 294(3) and Article 114 and Article 168(4)(c) of the Treaty on the Functioning of the European Union,
ob upoštevanju mnenja Evropskega ekonomsko-socialnega odbora z dne 10. junija 2009 UL C 306, 16.12.2009, str.
having regard to the opinion of the European Economic and Social Committee of 10 June 2009 OJ C 306, 16.12.2009, p.
ob upoštevanju mnenja Odbora regij z dne 7. oktobra 2009 UL C 79, 27.3.2010, str.
having regard to the opinion of the Committee of the Regions of 7 October 2009 OJ C 79, 27.3.2010, p.
ob upoštevanju zaveze predstavnika Sveta v pismu z dne 23. junija 2010, da bo odobril stališče Evropskega parlamenta v skladu s členom 294(4) Pogodbe o delovanju Evropske unije,
having regard to the undertaking given by the Council representative by letter of 23 June 2010 to approve Parliament's position, in accordance with Article 294(4) of the Treaty on the Functioning of the European Union,
ob upoštevanju poročila Odbora za okolje, javno zdravje in varnost hrane ter mnenj Odbora za industrijo, raziskave in energetiko ter Odbora za notranji trg in varstvo potrošnikov ( A7-0153/2010 ),
having regard to the report of the Committee on the Environment, Public Health and Food Safety and the opinions of the Committee on Industry, Research and Energy and the Committee on the Internal Market and Consumer Protection ( A7-0153/2010 ),
(Ker je bil dosežen sporazum med Parlamentom in Svetom, je stališče Parlamenta enako končnemu zakonodajnemu aktu, Uredbi (EU) št. 1235/2010.)
(As an agreement was reached between Parliament and Council, Parliament's position corresponds to the final legislative act, Regulation (EU) No 1235/2010.)
Komisija se na zahtevo Evropskega parlamenta in Sveta o razredu vodje Evropske agencije za zdravila z namenom, da se ne odloži sprejetje tega pomembnega predloga, zavezuje, da bo ponovno objavila razpis prostega delovnega mesta za naslednjega vodjo Evropske agencije za zdravila z razredom AD 15 namesto AD 14.
Following the request made by the European Parliament and the Council on the grading of the head of the European Medicines Agency, the Commission in order not to delay the adoption of this important proposal undertakes to re-publish the vacancy notice for the next head of the European Medicines Agency with the grade AD15 instead of AD14.
Komisija meni, da je zadevo primerno obravnavati v okviru trenutne horizontalne razprave o vlogi agencij EU v medinstitucionalni delovni skupini o agencijah.
The Commission considers that the right place to deal with the issue is the ongoing horizontal discussion on the role of EU agencies within the Inter-institutional working group on agencies.
Zakonodajna resolucija Evropskega parlamenta z dne 22. septembra 2010 o predlogu direktive Evropskega parlamenta in Sveta o spremembi Direktive 2001/83/ES o zakoniku Skupnosti o zdravilih za uporabo v humani medicini glede farmakovigilance ( KOM(2008)0665 – C6-0514/2008 – 2008/0260(COD) )
European Parliament legislative resolution of 22 September 2010 on the proposal for a directive of the European Parliament and of the Council amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use ( COM(2008)0665 – C6-0514/2008 – 2008/0260(COD) )
ob upoštevanju predloga Komisije Evropskemu parlamentu in Svetu ( KOM(2008)0665 ),
having regard to the Commission proposal to the European Parliament and the Council ( COM(2008)0665 ),
ob upoštevanju člena 251(2) in člena 95 Pogodbe ES, na podlagi katerih je Komisija Parlamentu podala predlog ( C6-0514/2008 ),
having regard to Article 251(2) and Article 95 of the EC Treaty, pursuant to which the Commission submitted the proposal to Parliament ( C6-0514/2008 ),
ob upoštevanju sporočila Komisije Evropskemu Parlamentu in Svetu z naslovom „Posledice začetka veljavnosti Lizbonske pogodbe za še nedokončane medinstitucionalne postopke odločanja“ ( KOM(2009)0665 ),
having regard to the Communication from the Commission to the European Parliament and the Council entitled ‘Consequences of the entry into force of the Treaty of Lisbon for ongoing interinstitutional decision-making procedures’ ( COM(2009)0665 ),
ob upoštevanju členov 294(3) ter 114 in 168(4)(c) Pogodbe o delovanju Evropske unije,
having regard to Article 294(3) and Articles 114 and 168(4)(c) of the Treaty on the Functioning of the European Union,
ob upoštevanju zaveze predstavnika Sveta v pismu z dne 23. junija 2010, da bo odobril stališče Parlamenta v skladu s členom 294(4) Pogodbe o delovanju Evropske unije,
having regard to the undertaking given by the Council representative by letter of 23 June 2010 to approve Parliament's position, in accordance with Article 294(4) of the Treaty on the Functioning of the European Union,
ob upoštevanju poročila Odbora za okolje, javno zdravje in varnost hrane ter mnenj Odbora za industrijo, raziskave in energetiko in Odbora za notranji trg in varstvo potrošnikov ( A7-0159/2010 ),
having regard to the report of the Committee on the Environment, Public Health and Food Safety and the opinions of the Committee on Industry, Research and Energy and the Committee on the Internal Market and Consumer Protection ( A7-0159/2010 ),
(Ker je bil dosežen sporazum med Parlamentom in Svetom, je stališče Parlamenta enako končnemu zakonodajnemu aktu, Direktivi 2010/84/EU.)
(As an agreement was reached between Parliament and Council, Parliament's position corresponds to the final legislative act, Directive 2010/84/EU.)
Zakonodajna resolucija Evropskega parlamenta z dne 22. septembra 2010 o predlogu uredbe Evropskega parlamenta in Sveta o dajanju v promet in uporabi biocidnih pripravkov ( KOM(2009)0267 – C7-0036/2009 – 2009/0076(COD) )
European Parliament legislative resolution of 22 September 2010 on the proposal for a regulation of the European Parliament and of the Council concerning the placing on the market and use of biocidal products ( COM(2009)0267 – C7-0036/2009 – 2009/0076(COD) )
ob upoštevanju predloga Komisije Parlamentu in Svetu ( KOM(2009)0267 ),
having regard to the Commission proposal to Parliament and the Council ( COM(2009)0267 ),
ob upoštevanju členov 251(2) in 95 Pogodbe ES, na podlagi katerih je Komisija Parlamentu podala predlog ( C7-0036/2009 ),
having regard to Article 251(2) and Article 95 of the EC Treaty, pursuant to which the Commission submitted the proposal to Parliament ( C7-0036/2009 ),
ob upoštevanju sporočila Komisije Evropskemu parlamentu in Svetu z naslovom „Posledice začetka veljavnosti Lizbonske pogodbe za še nedokončane medinstitucionalne postopke odločanja“ ( KOM(2009)0665 ),
having regard to the communication from the Commission to the European Parliament and the Council entitled: ‘Consequences of the entry into force of the Treaty of Lisbon for ongoing interinstitutional decision-making procedures’ ( COM(2009)0665 ),
ob upoštevanju člena 294(3) in člena 114 Pogodbe o delovanju Evropske unije,
having regard to Article 294(3) and Article 114 of the Treaty on the Functioning of the EU,
ob upoštevanju mnenja Evropskega ekonomsko-socialnega odbora z dne 17. februarja 2010 Še ni objavljeno v Uradnem listu.
having regard to the opinion of the European Economic and Social Committee of 17 February 2010 Not yet published in the Official Journal.
ob upoštevanju členov 55 in 37 Poslovnika,
having regard to Rules 55 and 37 of its Rules of Procedure,
ob upoštevanju poročila Odbora za okolje, javno zdravje in varnost hrane in mnenj Odbora za notranji trg in varstvo potrošnikov ter Odbora za industrijo, raziskave in energetiko ( A7-0239/2010 ),
having regard to the report of the Committee on the Environment, Public Health and Food Safety and the opinions of the Committee on the Internal Market and Consumer Protection and the Committee on Industry, Research and Energy ( A7-0239/2010 ),
EVROPSKI PARLAMENT IN SVET EVROPSKE SKUPNOSTI STA –
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
ob upoštevanju mnenja Evropskega ekonomsko-socialnega odbora Mnenje z dne 17. februarja 2010 (še ni objavljeno v Uradnem listu).
Having regard to the opinion of the European Economic and Social Committee Opinion of 17 February 2010 (not yet published in the Official Journal).
v skladu z rednim zakonodajnim postopkom Stališče Evropskega parlamenta z dne 22. septembra 2010.
Acting in accordance with the ordinary legislative procedure Position of the European Parliament of 22 September 2010.
Biocidni pripravki so potrebni za obvladovanje zdravju človeka ali živali škodljivih organizmov in za obvladovanje organizmov, ki povzročajo škodo naravnim ali izdelanim proizvodom.
Biocidal products are necessary for the control of organisms that are harmful to human or animal health and for the control of organisms that cause damage to natural or manufactured products.
Vendar lahko biocidni pripravki zaradi vsebovanih lastnosti, združenih z vzorci uporabe, pomenijo tveganje za človeka, živali in okolje.
However, biocidal products can pose risks to humans, animals and the environment due to their intrinsic properties and associated use patterns.
Biocidni pripravki se ne smejo dati v promet ali uporabljati, če ne ustrezajo dovoljenjem, izdanim v skladu s to uredbo.
Biocidal products should not be placed on the market or used unless they comply with the authorisation granted in accordance with this Regulation.
Namen te uredbe je povečati prosti pretok biocidnih pripravkov Uniji
The purpose of this Regulation is to increase the free movement of biocidal products within the Union
in zagotoviti visoko raven varovanja zdravja ljudi in živali ter okolja
and to ensure a high level of protection of both human and animal health and the environment
Določbe te uredbe bi morale biti podprte s previdnostnim načelom, da se zagotovi, da snovi ali pripravki, ki so proizvedeni ali dani v promet, nimajo nobenega škodljivega vpliva na zdravje ljudi ali živali ali nobenega nesprejemljivega vpliva na okolje.
The provisions of this Regulation should be underpinned by the precautionary principle in order to ensure that substances or products produced or placed on the market do not have any harmful effect on human or animal health or any unacceptable effects on the environment.
Da bi čim bolje odstranili ovire pri trgovini z biocidnimi pripravki, ▌bi bilo treba določiti ▌pravila za odobritev aktivnih snovi ter dajanje v promet in uporabo biocidnih pripravkov, vključno s pravili za vzajemno priznavanje dovoljenj in vzporedno trgovino.
In order to remove as far as possible obstacles to trade in biocidal products ▌, rules should be laid down for the approval of active substances and the placing on the market and use of biocidal products, including the rules on the mutual recognition of authorisations and on parallel trade.
Navedeni sistem je treba prilagoditi na podlagi poročila Komisije Svetu in Evropskem parlamentu z naslovom „Ocena izvajanja Direktive 98/8/ES o dajanju biocidnih pripravkov v promet (predloženo v skladu s členom 18(5) Direktive) in poročilo o napredku, doseženem s programom dela iz člena 16(2) iste direktive“ o prvih sedmih letih njenega izvajanja, in ki analizira težave in pomanjkljivosti navedene Direktive.
It is necessary to adapt that system on the basis of the report from the Commission to the Council and the European Parliament entitled ‘Evaluation of the implementation of Directive 98/8/EC concerning the placing of biocidal products on the market (submitted in accordance with Article 18(5) of the Directive) and progress Report on the work programme referred to in Article 16(2) of the same Directive’ on the first seven years of its implementation, which analyses the problems and weaknesses of that Directive.
Ob upoštevanju glavnih prilagoditev, ki so vključene v sedanji regulativni sistem, je uredba ustrezni pravni instrument za nadomestitev Direktive 98/8/ES, saj določa jasna in natančna pravila, ki državam članicam ne dopuščajo možnosti razhajanja pri prenosu.
Taking into account the main adaptations which are introduced in the existing regulatory system, a Regulation is the appropriate legal instrument to replace Directive 98/8/EC as it imposes clear and detailed rules which do not give room for diverging transposition by Member States.
Poleg tega se z uredbo zagotovi istočasno izvajanje pravnih obveznosti po vsej Uniji.
Moreover, a Regulation ensures that legal requirements are implemented at the same time throughout the Union.
Razlikovati je treba med obstoječimi aktivnimi snovmi, ki so bile v prometu v biocidnih pripravkih 14. maja 2000, in novimi aktivnimi snovmi, ki do tega datuma še niso bile v prometu v biocidnih pripravkih.
A difference should be made between existing active substances which were on the market in biocidal products on 14 May 2000 and new active substances which were not yet on the market in biocidal products by that date.
Navedeni datum je bil v Direktivi 98/8/ES prvotno določen kot datum, do katerega je bilo treba navedeno direktivo prenesti v nacionalno zakonodajo.
That date was initially set in Directive 98/8/EC as the date by which that Directive had to be transposed into national legislation.
Uvedeno je bilo razlikovanje med snovmi, ki so bile v prometu tega dne, in snovmi, ki navedenega dne niso bile v prometu.
A distinction was drawn between substances which were on the market on that date and those which were not.
Izvaja se delovni program za pregled vseh obstoječih snovi z namenom njihove vključitve v Prilogo I k Direktivi 98/8/ES.
A work programme is being carried out for the review of all existing substances with view to their inclusion in Annex I to Directive 98/8/EC.
Med opravljanjem revizije se lahko biocidni pripravki, ki vsebujejo obstoječe snovi, še naprej dajejo v promet, da se prepreči, da na trgu ne bi bilo na voljo nobenih biocidnih pripravkov.
During that review, biocidal products containing existing substances can continue to be placed on the market in order to prevent a situation where no biocidal products would be available on the market.
Preden se dajo biocidni pripravki, ki vsebujejo nove aktivne snovi, v promet, je treba te snovi pregledati, da se zagotovi, da se dajo v promet samo varni novi pripravki.
New active substances should be reviewed before biocidal products containing them can be placed on the market so as to ensure that only safe new products can be placed on the market.
Med potekom delovnega programa in najdlje do sprejetja odločitve o vključitvi aktivne snovi v Prilogo I k Direktivi 98/8/ES smejo države članice pod določenimi pogoji začasno izdati dovoljenje za biocidne pripravke, ki niso v skladu z določbami te uredbe.
During the work programme, and at most up until the decision on inclusion of the active substance in Annex I to Directive 98/8/EC, Member States may temporarily authorise biocidal products that do not comply with the provisions of this Regulation under certain conditions.
Po tem, ko države članice odločijo o vključitvi, v skladu s to uredbo izdajo, prekličejo ali spremenijo dovoljenje.
Following the decision on inclusion, Member States should grant, cancel or modify authorisations in accordance with this Regulation.
Da se zagotovi pravna varnost, je treba na ravni Unije izdelati seznam aktivnih snovi, ki jih je dovoljeno uporabljati v biocidnih pripravkih.
In order to ensure legal certainty, it is necessary to establish a Union list of active substances permitted for use in biocidal products.
Na ravni Unije treba predpisati postopek ocenjevanja, ali se neko aktivno snov lahko vpiše na seznam Unije ali ne.
A procedure should be laid down for assessing whether or not an active substance can be entered in the Union list.
Določiti je treba informacije, ki jih zainteresirane strani predložijo v podporo vključitve aktivne snovi na seznam Skupnosti.
The information that interested parties should submit in support of an inclusion of an active substance in the Union list should be specified.
Tveganja, povezana z izdelavo, uporabo in odstranjevanjem kemijske aktivne snovi ter materialov in izdelkov, tretiranih z njimi, je treba oceniti in upravljati podobno kot v Uredbi (ES) št. 1907/2006 Evropskega Parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH), o ustanovitvi Evropske Agencije za kemikalije UL L 396, 30.12.2006, str.
The risks associated with the production, use and disposal of a chemically active substance and materials and articles treated with it are to be assessed and managed in a similar way as they are in Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency OJ L 396, 30.12.2006, p.
Da bi dosegli visoko raven varovanja zdravja ljudi in okolja, se aktivne snovi z najvišjo stopnjo nevarnosti ne smejo odobriti za uporabo v biocidnih pripravkih, razen v posebnih okoliščinah.
With a view to achieving a high level of environmental and human health protection, active substances with the worst hazard profiles should not be approved for use in biocidal products except in specific situations.
Med te okoliščine spadajo dogodki, ko je odobritev upravičena, ker je izpostavljenost ljudi snovi zanemarljiva, iz javnozdravstvenih razlogov ali zaradi nesorazmernih negativnih učinkov morebitne nevključitve, če ni drugih možnosti.
These should include situations when the approval is justified because of a negligible exposure of humans to the substance, public health reasons or disproportionate negative impacts of a possible non-inclusion provided no alternatives exist.
Da bi se preprečila uporaba aktivnih snovi z najvišjo stopnjo nevarnosti, zlasti če njihova uporaba ni dovoljena v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet UL L 309, 24.11.2009, str.
In order to prevent the use of active substances with the worst hazard profiles, in particular when their use is not authorised under Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market OJ L 309, 24.11.2009, p.
, je ustrezno, da se njihova odobritev omeji na okoliščine, ko je izpostavljenost ljudi snovi zanemarljiva, ali je snov potrebna zaradi javnozdravstvenih razlogov.
, it is appropriate to restrict their approval to situations when the exposure of humans to the substance is negligible or the substance is necessary for public health reasons.
Zaradi upoštevanja razvojnih dosežkov v znanosti in tehnologiji je treba aktivne snovi na seznamu Unije redno preverjati.
The active substances in the Union list should be regularly examined to take account of developments in science and technology.